Garuda
PrivateLast Round
Series A
Extension
Mar 4, 2025
Total Funding Raised
$184M
Company Overview
Garuda Therapeutics is a biotechnology company focused on developing mechanism-based therapies for patients with blood, bone marrow, immune, and metabolic diseases through the use of advanced models like zebrafish, mice, and human-induced pluripotent stem cells to study novel genes and mechanisms critical for blood formation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Garuda Comps
Public and private peers based on sector, stage, and business model.
Garuda Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 4, 2025 | ||||
| Series B | Feb 7, 2023 | ||||
| Series A | Sep 23, 2021 |
Garuda Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ridgeback Capital | Series A |
| Mass General Brigham Innovation | Series A |
| OrbiMed | Series A Extension, Series B, Series A |
| Cormorant Capital | Series A |
| Northpond Ventures | Series A Extension |
| Alexandria Venture Investments | Series B |
| Aisling Capital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 4, 2025
$50M raised in Series A Extension round.
- Mar 3, 2025
Avanish Vellanki appointed as new President and Chief Executive Officer.
Garuda Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Garuda's valuation, stock price, and market status.
